Becker's Healthcare October 25, 2024
Researchers have recently identified more potential uses for Ozempic and other GLP-1 medications, including treating opioid use disorder, alcohol use disorder and Alzheimer’s disease.
Here’s what to know:
1. Alzheimer’s disease
Semaglutide, the active ingredient of Ozempic, Wegovy and Rybelsus, was associated with a significantly lower risk for first-time Alzheimer’s disease diagnosis, according to research published Oct. 24 in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
The study, conducted by researchers from Case Western Reserve School of Medicine in Cleveland, analyzed nearly 1 million records of patients with Type 2 diabetes. Compared to other antidiabetic medicines, patients who took semaglutide had a 40% to 70% reduced risk of a first-time Alzheimer’s diagnosis.
2. Opioid and...
Today's Sponsors
Today's Sponsor